Actinogen Medical Limited

ASX:ACW Lagerbericht

Marktkapitalisierung: AU$73.6m

Actinogen Medical Management

Management Kriterienprüfungen 2/4

Actinogen Medical's CEO is Steve Gourlay, appointed in Mar 2021, has a tenure of 3.67 years. total yearly compensation is A$754.11K, comprised of 54.7% salary and 45.3% bonuses, including company stock and options. directly owns 3.28% of the company’s shares, worth A$2.41M. The average tenure of the management team and the board of directors is 2.3 years and 6.9 years respectively.

Wichtige Informationen

Steve Gourlay

Geschäftsführender

AU$754.1k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts54.7%
Amtszeit als Geschäftsführer3.7yrs
Eigentum des Geschäftsführers3.3%
Durchschnittliche Amtszeit des Managements2.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.9yrs

Jüngste Management Updates

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Apr 30
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Steve Gourlay im Vergleich zu den Einnahmen von Actinogen Medical verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024AU$754kAU$412k

-AU$13m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$13m

Jun 30 2023AU$657kAU$396k

-AU$11m

Mar 31 2023n/an/a

-AU$11m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$10m

Jun 30 2022AU$955kAU$376k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$271kAU$112k

-AU$4m

Vergütung im Vergleich zum Markt: Steve's total compensation ($USD498.06K) is above average for companies of similar size in the Australian market ($USD299.27K).

Entschädigung vs. Einkommen: Steve's compensation has increased whilst the company is unprofitable.

Geschäftsführer

Steve Gourlay (65 yo)

3.7yrs

Amtszeit

AU$754,111

Vergütung

Dr. Steven G. Gourlay, also known as Steve, MBBS (M.D.), Ph D., FRACP, M.B.A., serves as Chief Executive Officer at Actinogen Medical Limited since March 15, 2021 and as its Managing Director and Director...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Steven Gourlay
MD, CEO & Director3.7yrsAU$754.11k3.28%
A$ 2.4m
William Souter
Chief Financial Officerless than a yearAU$476.62k0.014%
A$ 10.0k
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board1.8yrsAU$913.27kkeine Daten
Michael Roberts
Head of Investor Relations & Corporate Communications3.5yrskeine Datenkeine Daten
Paul Rolan
Head of Clinical Pharmacology & Lead Physician and Depression2.8yrsAU$191.66kkeine Daten
Fujun Li
Head of Manufacturing1.3yrskeine Datenkeine Daten
Andrew Udell
Chief Commercial Officerless than a yearkeine Datenkeine Daten
Peter Webse
Company Secretary11.1yrskeine Datenkeine Daten

2.3yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrenes Management: ACW's management team is considered experienced (2.3 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Steven Gourlay
MD, CEO & Director3.7yrsAU$754.11k3.28%
A$ 2.4m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board2.8yrsAU$913.27kkeine Daten
George Morstyn
Independent Non-Executive Director6.9yrsAU$114.27k0.41%
A$ 299.4k
Geoffrey Edward Brooke
Independent Non-Executive Chairman7.7yrsAU$234.39k0.64%
A$ 471.4k
Colin Masters
Member of Xanamem Clinical Advisory Board9.7yrskeine Datenkeine Daten
Jeffrey Cummings
Member of Xanamem Clinical Advisory Board9.7yrskeine Datenkeine Daten
Malcolm McComas
Independent Non-Executive Director5.6yrsAU$114.27k0.24%
A$ 179.3k
John Harrison
Member of Depression & Cognition Clinical Advisory Board2.8yrskeine Datenkeine Daten
Craig Ritchie
Chairman of Xanamem Clinical Advisory Board9.7yrskeine Datenkeine Daten
Jonathan Seckl
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Brian Walker
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Scott Webster
Member of Scientific Advisory Boardno datakeine Datenkeine Daten

6.9yrs

Durchschnittliche Betriebszugehörigkeit

71yo

Durchschnittliches Alter

Erfahrener Vorstand: ACW's board of directors are considered experienced (6.9 years average tenure).